ClinVar Miner

Submissions for variant NM_152296.5(ATP1A3):c.2266C>T (p.Arg756Cys)

dbSNP: rs1064797245
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV000488196 SCV000575190 likely pathogenic not provided 2016-09-30 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000501825 SCV000593519 likely pathogenic Alternating hemiplegia of childhood 2 2016-06-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV000624914 SCV000741354 pathogenic Inborn genetic diseases 2016-02-16 criteria provided, single submitter clinical testing
Invitae RCV000692668 SCV000820504 pathogenic Dystonia 12 2023-09-24 criteria provided, single submitter clinical testing ClinVar contains an entry for this variant (Variation ID: 425189). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 756 of the ATP1A3 protein (p.Arg756Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with rapid onset of ataxia, encephalopathy, dystonia, and weakness following a febrile illness (PMID: 26400718, 27268479, 27634470, 27726050, 29066118, 29397530). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000850500 SCV000992700 likely pathogenic Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome; Dystonia 12; Alternating hemiplegia of childhood 2 2018-10-12 criteria provided, single submitter clinical testing
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000488196 SCV001446978 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
GeneDx RCV000488196 SCV001793155 pathogenic not provided 2023-05-25 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29396171, 8496742, 27726050, 22842232, 34765691, 34761051, 34975730, 26400718, 24436111, 19652145, 24123283, 23483595, 27091223, 26297560, 25895915, 26410222, 28293679, 16632466, 22534615, 24739246, 24468074, 29184165, 25656163, 15260953, 24996492, 25359261, 22850527, 29397530, 28647130, 27634470, 27268479, 29346770, 29066118, 30862413, 31269555, 31737037, 32637629, 31216405, 31175295)
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV000501825 SCV002512690 pathogenic Alternating hemiplegia of childhood 2 2021-07-15 criteria provided, single submitter clinical testing ACMG classification criteria: PS4 moderate, PM2 moderate, PM5, PM6 strong, PP1 moderate, PP3 supporting
Revvity Omics, Revvity RCV000488196 SCV003811134 pathogenic not provided 2022-03-29 criteria provided, single submitter clinical testing
Baylor Genetics RCV000692668 SCV003836469 pathogenic Dystonia 12 2022-03-25 criteria provided, single submitter clinical testing
Institute of Human Genetics, University Hospital of Duesseldorf RCV003335375 SCV004046815 pathogenic Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome criteria provided, single submitter not provided
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000488196 SCV001739883 pathogenic not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000488196 SCV001952062 pathogenic not provided no assertion criteria provided clinical testing
GeneReviews RCV000692668 SCV002559236 not provided Dystonia 12 no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.